Search

Your search keyword '"Netravathi, M"' showing total 430 results
Start Over Author "Netravathi, M"
430 results on '"Netravathi, M"'

2. Rituximab-Induced Hypersensitivity Pneumonitis in Multiple Sclerosis: A Rare Phenomenon

Author

Jayanth, SS, Jain, Kshiteeja, Mohan, BV Murali, and Netravathi, M

Subjects
Medical research, Medicine, Experimental, Multiple sclerosis -- Drug therapy -- Physiological aspects, Hypersensitivity pneumonitis -- Physiological aspects -- Risk factors -- Case studies, Health
Abstract

Author(s): SS Jayanth [1]; Kshiteeja Jain [1]; BV Murali Mohan [2]; M Netravathi (corresponding author) [1] Dear Editor, Multiple sclerosis (MS) is an autoimmune condition characterized by the involvement of [...]

Published
2025
Full Text
View/download PDF

5. Impact of Cognitive and Psychological Functions in Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional Study

Author

Yadav, Vinayaka, Hegde, Shantala, Netravathi, M, Philip, Mariamma, and Cranberg, Lee

Subjects
Diagnosis, Care and treatment, Health aspects, Cognitive disorders -- Diagnosis -- Care and treatment, Multiple sclerosis -- Diagnosis -- Care and treatment, Quality of life -- Health aspects, Cognition disorders -- Diagnosis -- Care and treatment
Abstract

Author(s): Vinayaka Yadav [1]; Shantala Hegde (corresponding author) [1]; M Netravathi [2]; Mariamma Philip [3]; Lee Cranberg [4] Introduction Multiple sclerosis (MS) is a chronic autoimmune disease of the central [...], Background and Objectives: To compare the cognitive functions and trait anxiety in patients diagnosed with relapsing-remitting multiple sclerosis (RRMS) to those of matched healthy controls (HCs). In addition, the study aims to investigate the correlations among cognitive functions, anxiety, depression, and quality of life (QOL) in this clinical population. Methods: The sample included RRMS patients (n = 21) and an equal number of age-, education-, and sex-matched HCs. Participants were assessed on the Indian version of the Wechsler Adult Intelligence Scale-IV, auditory and visual learning and memory, and visual-spatial construction and memory. RRMS patients were also assessed for levels of anxiety, depression, and their QOL. Comparative analyses between RRMS patients and HCs were carried out for neuropsychological assessments. Correlations among cognitive functions, anxiety, depression, and QOL in RRMS patients were examined. Results: RRMS patients showed significant deficits across various cognitive domains, including processing speed and verbal learning, compared to HCs (P < 0.05). In addition, they reported higher levels of trait anxiety compared to HCs (P < 0.01), along with moderate state anxiety and mild depression. A significant correlation among anxiety, depression, and QOL was observed in RRMS patients. Conclusions: This study highlights significant cognitive impairments and psychological distress experienced by RRMS individuals, underscoring the critical need for comprehensive care addressing both cognitive impairments and psychological distress to enhance QOL. Keywords: Multiple sclerosis, state-trait anxiety, depression, quality of life

Published
2024
Full Text
View/download PDF

6. Movement disorders in autoimmune encephalitis: Clinical spectrum, prognosis, and outcomes from an Indian cohort

Author

Shreyashi Jha, Netravathi M, Vikram Venkappayya Holla, Nitish Kamble, Anita Mahadevan, and Pramod Kumar Pal

Subjects
autoimmune encephalitis, movement disorders, nmda, Neurology. Diseases of the nervous system, RC346-429
Abstract

BACKGROUND: Antibody-mediated autoimmune encephalitis (AE) encompasses inflammatory central nervous system disorders linked etiologically with neuronal autoantibodies. Movement disorders (MDs) are common and diverse in AE, and their early identification can expedite effective management. Current literature on MDs in AE is limited to a few case reports and series, synthesized into multiple systematic reviews. Furthermore, there is a lack of literature on MDs in seronegative AE and their prognostic factors. We aimed to characterize the age-specific phenomenology, therapeutic responses, outcomes, and prognostic factors of MDs in a large cohort of patients with seropositive and seronegative AE. METHODS: This was a chart review of all patients with AE over three years (January 2018 to January 2021) at a tertiary center in Southern India. RESULTS: MDs were found to be prevalent among 47 (72.3% females) of 74 patients (63.5%) with AE. Dystonia was the most common (31.9%). Oro-facial-lingual-dyskinesias (OFLD), opsoclonus-myoclonus syndrome (OMS), and tics were prevalent in patients aged below 18 years. The most common MDs among patients with NMDAR antibody encephalitis were OFLD (60%), facio-brachial-dystonic seizures (FBDS) among all four patients with LGI-1 antibody encephalitis, myoclonus (50.0%) in the CASPR2 antibody encephalitis cohort and dystonia (80%) among patients with seronegative AE. Parkinsonism and FBDS were commonly observed in patients above 45 years of age (P < 0.001). Good response to immunotherapy was observed in 91.4%. Multivariate regression analysis demonstrated that preceding Japanese encephalitis infection, ICU stay, and delay in immunotherapy were poor prognostic factors. CONCLUSIONS: Patients above 45 years of age presented with hypokinetic MD while hyperkinetic MD were frequent in patients below 18 years of age. Hypokinetic MD had a worse prognosis.

Published
2024
Full Text
View/download PDF

7. Therapeutic role of plasma exchange in the management of stiff person syndrome: experience from a tertiary care centre

Author

Vijay Kumawat, Parmatma Prasad Tripathi, Netravathi M, Anita Mahadevan, and Anchan Vidyashree Vittal

Subjects
Stiff person syndrome, Therapeutic plasma exchange, Anti-GAD65 antibodies, Modified Rankin score, Diseases of the blood and blood-forming organs, RC633-647.5
Abstract

Introduction: The stiff person syndrome (SPS) is a rare and disabling neurological disorder characterized by muscle stiffness, painful spasms and rigidity involving the proximal and axial limb muscles, with an estimated incidence of 1 case per million per year. The first line of treatment for symptomatic management includes gamma-aminobutyric acid (GABA)ergic agonists, benzodiazepines and baclofen. The therapeutic plasma exchange (TPE), alone or as an adjuvant to other forms of immunomodulation, has been used as a therapeutic option, particularly in refractory cases. Methods: An observational study was performed to review SPS patient symptoms, comorbidities, electromyography (EMG) studies and treatment, identifying autoantibodies, therapeutic plasma exchange (TPE) procedural details and clinical response. Main results: Five patients (4 male and one female) were treated with TPE during the study period as adjuvant therapy. The average age was 47 years (range 34 - 61 years), and anti-glutamic acid decarboxylase 65-kilodalton isoform (anti-GAD65) antibodies were positive in 80 % (4/5) of the patient population. All patients received immunosuppressive drugs along with TPE. Four patients received TPE during the first admission and one received it during the third hospital admission. All patients showed good improvement immediately after TPE, but it was not a sustainable effect. Conclusion: TPE may be helpful as adjuvant therapy for SPS patients to provide relief from clinical symptoms

Published
2024
Full Text
View/download PDF

8. Autoimmune Encephalitis

Author

Netravathi, M., Oli, Krishna Kumar, editor, Shrestha, Gentle Sunder, editor, Ojha, Rajeev, editor, Pal, Pramod Kumar, editor, Pandey, Sanjay, editor, and Das, Bibhukalyani, editor

Published
2024
Full Text
View/download PDF

9. Tubercular Meningitis

Author

Netravathi, M., Oli, Krishna Kumar, editor, Shrestha, Gentle Sunder, editor, Ojha, Rajeev, editor, Pal, Pramod Kumar, editor, Pandey, Sanjay, editor, and Das, Bibhukalyani, editor

Published
2024
Full Text
View/download PDF

10. Anti-glutamic acid decarboxylase antibodies-associated cerebellar ataxia: A treatable ataxia

Author

Rohan Mahale, Sandeep M, Anita Mahadevan, Nitish Kamble, Vikram Holla, Ravindranadh Mundlamuri, Seena Vengalil, Netravathi M, Atchayaram Nalini, Pramod Kumar Pal, and Ravi Yadav

Subjects
anti-gad65 antibodies, cerebellar ataxia, glutamic acid decarboxylase, neoplasm, Neurology. Diseases of the nervous system, RC346-429
Abstract

BACKGROUND: Anti-glutamate decarboxylase 65 antibody-associated cerebellar ataxia (anti-GAD65Ab-associated CA) is the most widely studied immune-mediated CA. There are few case series evaluating the clinical, radiological, treatment profile, and outcome of anti-GAD65Ab-associated CA. OBJECTIVE: To study the clinical, radiological profile, associated neoplasm, treatment outcome, and prognosis in patients diagnosed with anti-GAD65Ab-associated CA. METHODS: A retrospective descriptive analysis of a cohort of patients diagnosed with anti-GAD65Abassociated CA was performed and analyzed. RESULTS: Thirteen patients were selected for the analysis with female predominance (70%). The mean age at presentation was 47.5 } 11.1 years (range, 29–65 years), and the median duration of the symptoms was 4 months. All 13 patients (100%) had gait ataxia. Ten patients had limb ataxia along with gait ataxia (75%). Seven patients had cerebellar dysarthria (54%). Four patients (31%) had gazeevoked jerky nystagmus. Five patients (39%) were diagnosed with type 2 diabetes mellitus, and one patient had hypothyroidism in addition to type 2 diabetes mellitus. Brain magnetic resonance imaging was normal in seven (54%) patients, and pure cerebellar atrophy was observed in six patients. One patient was detected with a colon neoplasm. All 13 patients received intravenous methylprednisolone, followed by oral steroids over 3 months. Six patients (50%) received plasma exchange along with intravenous methylprednisolone. Favorable outcomes (modified Rankin scale score 2) were observed in five patients and poor outcomes in two; six patients were lost to follow-up after the first admission. CONCLUSION: Anti-GAD65Ab-associated CA presents as subacute to chronic progressive CA with a favorable outcome with immunotherapy. Anti-GAD antibodies should be assessed in serum or cerebrospinal fluid in patients presenting subacute to chronic sporadic CA. The occurrence of a systemic neoplasm is rare in anti-GAD65Ab-associated CA.

Published
2024
Full Text
View/download PDF

14. The India brain infections guidelines project: Global evidence for local application

Author

Priscilla Rupali, Bhagteshwar Singh, Naveena Gracelin Princy, Jisha Sara John, Rebecca Kuehn, Tom Solomon, Hanna Alexander, Prathap Tharyan, G. Singh, Ramasubramanian V, Joseph L. Mathew, Netravathi M, and Paul Garner

Subjects
Guideline development, GRADE methodology, India, Brain infections, Encephalitis, Meningitis, Public aspects of medicine, RA1-1270
Abstract

Background: Brain infections are a major cause of morbidity and mortality globally. India lacks systematically evidence-informed guidelines for brain infections. Methods: We had set up a group of experts in brain infections, evidence synthesis and guideline development to produce guidelines for hospital clinicians diagnosing and treating patients with suspected and confirmed brain infections in India. Questions are being drafted and prioritised, and a plan for GRADE-informed evidence synthesis and guideline development is in place, using methods to increase efficiency of the process where possible. Dissemination and outputs: The guidelines will be disseminated through publication as well as on a dedicated website. Training of clinicians in evidence synthesis and guideline development, and setting up a network of institutions and professional societies, will provide lasting impact in terms of national capacity strengthening.

Published
2024
Full Text
View/download PDF

15. Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition

Author

Frontera, Jennifer A., Guekht, Alla, Allegri, Ricardo F., Ashraf, Mariam, Baykan, Betül, Crivelli, Lucía, Easton, Ava, Garcia-Azorin, David, Helbok, Raimund, Joshi, Jatin, Koehn, Julia, Koralnik, Igor, Netravathi, M., Michael, Benedict, Nilo, Annacarmen, Özge, Aynur, Padda, Karanbir, Pellitteri, Gaia, Prasad, Kameshwar, Romozzi, Marina, Saylor, Deanna, Seed, Adam, Thakur, Kiran, Uluduz, Derya, Vogrig, Alberto, Welte, Tamara M., Westenberg, Erica, Zhuravlev, Dmitry, Zinchuk, Mikhail, and Winkler, Andrea S.

Published
2023
Full Text
View/download PDF

16. Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study

Author

Abbariao, Maritoni, Zaki, Shafiq Dexter Abou, Aleksic, Dejan, Aliling, Nicole, Rivas, Susana Arias, Artajos, Godard, Asukile, Melody, Atalar, Arife Çimen, Bae, Jong Seok, Banzrai, Chimeglkham, Bar, Michal, Barone, Valentina, Baykan, Betul, Beghi, Ettore, Berger, Thomas, Bilic, Ivica, Biller, Jose, Boskovic, Mateja, Cabreira, Verónica, Calado, Sofia, Canete, Maria Teresa, Celebisoy, Nese, Chen, Ike Leon, Chishimba, Lorraine, Chomba, Mashina, Constantino, Glenn Anthony, Cotelli, Maria Sofia, De Cauwer, Harald, Debroucker, Thomas, Orantes, Luis Del Carpio, Devaraj, Rashmi, D'Souza, Michelle, Ekizoglu, Esme, Elmali, Ayse Deniz, Fonseca, Ana Catarina, Furloni, Roberto, Gajre, Sunil, Azorin, David Garcia, Garfoot, Vanessa, Gasparic, Irena, Genç, Hamit, Glavica, Marinka, Guanaes, Luiz Gustavo, Gürsoy, Gizem, Hafiz, Nauman, Hasırcı, Buse, Helbok, Raimund, Hor, Chee Peng, Hughes, Stella, Hwang, Sungeun, Kaya, Irem Ilgezdi, Jakupi, Adi, Jamora, Roland Dominic, Kahwagi, Jamil, Kaprelyan, Ara, Kawatu, Nfwama, Kim, Manho, Kim, Hyunji, Kim, Hyun Kyung, Koffie, Desmond, Ladeira, Filipa, Lant, Suzannah, Lee, Woo-Jin, Lee, Sukyoon, Leonardo, Zerlyn, Lim, Christian Emmanuel, Lisak, Marijana, Loh, Hong Chuan, Loo, Lay Khoon, Huzjan, Arijana Lovrencic, Koh, Rosie Sue Luan Lu, Luabeya, Mesu'a Kabwa, Lugaresi, Alessandra, Macrohon, Bernadette, Majdak, Maja, Manalili, Sheryl, Manelli, Filippo, Mapoure, Yacouba Njankouo, Mascarella, Davide, Massano, João, Mataa, Mataa, Matibag, Jessica Leika, Matic-Gerodias, Alexandria, McMullen, Kate, Miranda, Miguel, Modequillo, Margaret, Shoab, Abul Kalam Mohammed, Motto, Cristina, Murphy, Sinead M., Mwendaweli, Naluca, Ng, Chen Fei, Ng, Rong Xiang, Ihsan, Mohd Khairul Nizam Nor, Nyein, Aye Myat, O'Connell, Karen, Oh, Seong-il, Ohnmar, Ohnmar, Özge, Aynur, Pajo, Azalea, Palavra, Filipe, Panteleienko, Larysa, Payne, Catherine, Pensato, Umberto, Peres, João, Peters, Steven, Polat, Burcu, Poljakovic, Zdravka, Punter, Martin Nicholas Michael, Quiles, Liz Edenberg, Ranieri, Angelo, Ratković, Marija, Renales, Maria Lina, Robles, Jose, Bedeković, Marina Roje, Rommer, Paulus, Šapina, Lidija, Sarac, Helena, Saylor, Deanna, Schmutzhard, Erich, Sharma, Anahita, Šimić, Aleksandra, Sipilä, Jussi O.T., Sokhi, Dilraj, Stagno, Mauro, Stancheva, Kristina, Stojsavljević, Marija, Subir, Ahamed, Surdhar, Sushee, Talabucon, Loreto, Jr, Tan, Hui Jan, Teoh, Sing Chiek, Vallejo, Dionis, Velioglu, Sibel K., Vukasović, Rafaela, Kit, Wong Wai, Welte, Tamara, Willekens, Barbara, Yesilot, Nilufer, Yu, Jeryl Ritzi T., Zaw, Moe Moe, Zhelyazkova, Sashka, Žitnik, Eva, Tamborska, A.A., Wood, G.K., Westenberg, E., Garcia-Azorin, D., Webb, G., Schiess, N., Netravathi, M., Baykan, B., Dervaj, R., Helbok, R., Lant, S., Özge, A., Padovani, A., Saylor, D., Schmutzhard, E., Easton, A., Lilleker, J.B., Jackson, T., Beghi, E., Ellul, M.A., Frontera, J.A., Pollak, T., Nicholson, T.R., Wood, N., Thakur, K.T., Solomon, T., Stark, R.J., Winkler, A.S., and Michael, B.D.

Published
2023
Full Text
View/download PDF

17. Co-VAN study: COVID-19 vaccine associated neurological diseases- an experience from an apex neurosciences centre and review of the literature

Author

Samim, M.M., Dhar, Debjyoti, Arshad, Faheem, Anudeep, D.D.S., Patel, Vishal G., Neeharika, Sriram Ramalakshmi, Dhamija, Kamakshi, Ravindranath, Chowdary Mundlamuri, Yadav, Ravi, Raja, Pritam, Netravathi, M., Menon, Deepak, Holla, Vikram V., Kamble, Nitish L., Pal, Pramod K., Nalini, Atchayaram, and Vengalil, Seena

Published
2023
Full Text
View/download PDF

18. A real world multi center study on efficacy and safety of natalizumab in Indian patients with multiple sclerosis

Author

Mathew, Thomas, Kamath, Vikram, John, Saji K, Netravathi, M, Iyer, Rajesh B, Raghavendra, S, Kumar, Suresh, Neeharika, M.L., Gupta, Salil, Murgod, Uday, Shivakumar, R., Annadure, Ravi K, Ichaporia, Nasli, Rohatgi, Anshu, Nair, Sruthi S, Yareeda, Sireesha, Anand, Bawani, Singh, Prabhjeet, Renukaradhya, Umashankar, Arulselvan, V., Reddy, Y Muralidhar, Surya, Nirmal, Sarma, G.R.K., Nadig, Raghunandan, Deepalam, Saikanth, Sharath Kumar, G.G., Satishchandra, P., Singhal, Bhim Sen, and Parry, Gareth

Published
2022
Full Text
View/download PDF

24. Outpatient Neuropalliative Care Services in a Tertiary Hospital Setting

Author

Thomas, Priya T., primary, Kumar, Gargi S., additional, Baby, Priya, additional, Vengalil, Seena, additional, Srijithesh, P. R., additional, Yamini, B. K., additional, Netravathi, M, additional, Yadav, Ravi, additional, Pandian, R. Dhanasekhara, additional, Gupta, Anupam, additional, Alladi, Suvarna, additional, and Nalini, Atchayaram, additional

Published
2024
Full Text
View/download PDF

27. An unusual cause for cauda equina and spastic paraparesis: Two cases of brucellar arachnoiditis without spondylodiscitis or constitutional symptoms

Author

Menon, Deepak, Varghese, Nibu, Nagarathna, Siddaiah, Saini, Jitender, and Netravathi, M.

Subjects
Complications and side effects, Case studies, Causes of, Arachnoiditis -- Case studies -- Complications and side effects, Cauda equina -- Case studies -- Causes of, Brucellosis -- Case studies -- Complications and side effects, Spastic paraplegia -- Case studies -- Causes of, Paralysis, Spastic -- Case studies -- Causes of
Published
2022

28. FDG-PET in autoimmune encephalitis: Utility, pattern of abnormalities, and correlation with autoantibodies

Author

Jha, Shreyashi, Nagaraj, Chandana, Mundlamuri, R., Alladi, Suvarna, Nashi, Saraswati, Kenchaiah, Raghavendra, Mahadevan, Anita, Bhat, Maya, Saini, Jitender, and Netravathi, M.

Subjects
Diagnosis, Usage, Health aspects, Autoimmune diseases -- Diagnosis, Positron emission tomography -- Usage, Autoantibodies -- Health aspects, Encephalitis -- Diagnosis, Radioactive tracers -- Usage, PET imaging -- Usage
Published
2022

29. Deciphering the footprints of autoimmunity in CNS demyelinating disorders

Author

Netravathi, M.

Subjects
Physiological aspects, Development and progression, Prognosis, Health aspects, Demyelinating diseases -- Development and progression -- Prognosis, Autoimmunity -- Health aspects, Antibodies -- Physiological aspects -- Health aspects, Viral antibodies -- Physiological aspects -- Health aspects
Published
2022

36. The spectrum of Neuro-COVID: A study of a comprehensively investigated large cohort from India

Author

Vengalil, Seena, Mahale, Rohan, Chakradhar, N., Alluri, Swathi, Navanith, P. Sagar, Ganaraja, V., Haripriya, K., Vikram, Holla, Asranna, Ajay, Mailankody, Pooja, Seshagiri, Doniparthi, Cheerla, H., Maturu, V., Vaddepally, C., Kenchaiah, Raghavendra, Srijithesh, P., Chaudhuri, Jaydip, Netravathi, M., and Alladi, Suvarna

Subjects
Statistics, Complications and side effects, Risk factors, Nervous system diseases -- Statistics -- Risk factors, COVID-19 -- Statistics -- Complications and side effects, Neurologic manifestations -- Statistics -- Risk factors, Neurologic manifestations of general diseases -- Statistics -- Risk factors
Published
2022

37. Biotin-Responsive Basal Ganglia Disease: Treatable Metabolic Disorder with SLC19A3 Mutation Presenting as Rapidly Progressive Dementia

Author

Oommen, Abel, Polavarapu, K., Christopher, R., and Netravathi, M.

Subjects
Diagnosis, Drug therapy, Usage, Case studies, Extrapyramidal disorders -- Diagnosis -- Drug therapy -- Case studies, Dementia -- Case studies -- Diagnosis, Metabolic diseases -- Case studies -- Diagnosis -- Drug therapy, Gene mutation -- Case studies, Biotin -- Case studies -- Usage, Gene mutations -- Case studies
Published
2022

41. Recurrent posterior circulation stroke as an initial manifestation of atlantoaxial dislocation in a child

Author

Devavrat, N., K, Karthik, Shumyla, J., Neeraja, K., and Netravathi, M.

Subjects
Diagnosis, Complications and side effects, Case studies, Risk factors, Health aspects, Pediatric research, Neck injuries -- Case studies -- Diagnosis -- Complications and side effects, Recurrence (Disease) -- Case studies -- Risk factors, Atlantoaxial joint -- Case studies -- Health aspects, Stroke -- Case studies -- Risk factors, Dislocations -- Case studies -- Complications and side effects, Stroke (Disease) -- Case studies -- Risk factors, Neck -- Injuries, Diseases -- Relapse, Atlanto-axial joint -- Case studies -- Health aspects
Published
2021

43. Corrigendum to “Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study” [Journal of the Neurological Sciences. 2023 Jun 15;449:120646]

Author

Tamborska, A.A., primary, Wood, G.K., additional, Westenberg, E., additional, Garcia-Azorin, D., additional, Webb, G., additional, Schiess, N., additional, Netravathi, M., additional, Baykan, B., additional, Dervaj, R., additional, Helbok, R., additional, Lant, S., additional, Özge, A., additional, Padovani, A., additional, Saylor, D., additional, Schmutzhard, E., additional, Easton, A., additional, Lilleker, J.B., additional, Jackson, T., additional, Beghi, E., additional, Ellul, M.A., additional, Frontera, J.A., additional, Pollak, T., additional, Nicholson, T.R., additional, Wood, N., additional, Thakur, K.T., additional, Solomon, T., additional, Stark, R.J., additional, Winkler, A.S., additional, and Michael, B.D., additional

Published
2023
Full Text
View/download PDF

45. Integration of teleneurology within the health system to manage patients of multiple sclerosis and other CNS demyelinating disorders during COVID-19 pandemic

Author

Thomas, Priya, Annam, Harikrishna, Ravindu, Warrier, Manjusha, and Netravathi, M.

Subjects
Control, Technology application, Care and treatment, Usage, Demyelinating diseases -- Care and treatment, Telemedicine -- Usage, Epidemics -- Control -- India, Multiple sclerosis -- Care and treatment, COVID-19 -- Control, Neurology -- Technology application
Published
2021

49. Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study

Author

Tamborska, A.A., primary, Wood, G.K., additional, Westenberg, E., additional, Garcia-Azorin, D., additional, Webb, G., additional, Schiess, N., additional, Netravathi, M., additional, Baykan, B., additional, Dervaj, R., additional, Helbok, R., additional, Lant, S., additional, Özge, A., additional, Padovani, A., additional, Saylor, D., additional, Schmutzhard, E., additional, Easton, A., additional, Lilleker, J.B., additional, Jackson, T., additional, Beghi, E., additional, Ellul, M.A., additional, Frontera, J.A., additional, Pollak, T., additional, Nicholson, T.R., additional, Wood, N., additional, Thakur, K.T., additional, Solomon, T., additional, Stark, R.J., additional, Winkler, A.S., additional, and Michael, B.D., additional

Published
2023
Full Text
View/download PDF

50. Acute Necrotizing Encephalopathy as a Complication of Chikungunya Infection

Author

Holla, V., Gohel, Abhishek, Kartik, N., and Netravathi, M.

Subjects
Drug therapy, Complications and side effects, Case studies, Causes of, Pediatric research, Chikungunya fever -- Case studies -- Complications and side effects, Encephalopathy -- Case studies -- Drug therapy -- Causes of
Published
2021

Catalog

Books, media, physical & digital resources
See catalog results